Literature DB >> 475517

Hemodialysis in the eighth and ninth decades of life.

A C Chester, T A Rakowski, W P Argy, A Giacalone, G E Schreiner.   

Abstract

In a review of 45 patients who started receiving hemodialysis (HD) after the age of 70 years (mean, 75 years), compared with a control of 70 HD patients (mean age, 42 years), the two-year survival for elderly patients was 42% and 58% for controls. In the elderly group, age did not correlate with survival. Nine elderly patients were over 80 years old and had a two-year survival of 41%. The elderly patients had a significantly lower mean predialysis blood pressure (BP) (142/73 +/- 3/1 mm Hg) than the controls (158/88 +/- 2/1 mm Hg) (P less than .001). Only 13% of the elderly patients received antihypertensive medication, compared with 41% of controls (P less than .01). The BP showed a significant negative correlation with age in both elderly ( r - .41, P less than .01) and control (r = .35, P less than .001) patients. Glomerulonephritis was less common in the elderly (9%) than control (31%) groups, and pyelonephritis was more common (29% vs 16%).

Entities:  

Mesh:

Year:  1979        PMID: 475517

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Factors associated with initiation of chronic renal replacement therapy for patients with kidney failure.

Authors:  Labib I Faruque; Brenda R Hemmelgarn; Natasha Wiebe; Braden J Manns; Pietro Ravani; Scott Klarenbach; Rick Pelletier; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

2.  Factors associated with hospitalization in a sample of chronic hemodialysis patients.

Authors:  K R Jones
Journal:  Health Serv Res       Date:  1991-12       Impact factor: 3.402

Review 3.  Hemodialysis in elderly patients.

Authors:  W W Brown
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.266

4.  Cross-national differences in dialysis rates.

Authors:  J Prottas; M Segal; H M Sapolsky
Journal:  Health Care Financ Rev       Date:  1983-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.